CD30 contains two binding sites with different specificities for members of the tumor necrosis factor receptor-associated factor family of signal transducing proteins - Wikidata - awgldk - TriplyDB

CD30 contains two binding sites with different specificities for members of the tumor necrosis factor receptor-associated factor family of signal transducing proteins

CD30 contains two binding sites with different specificities for members of the tumor necrosis factor receptor-associated factor family of signal transducing proteins

http://www.wikidata.org/entity/Q28281794

about

TTRAP, a novel protein that associates with CD40, tumor necrosis factor (TNF) receptor-75 and TNF receptor-associated factors (TRAFs), and that inhibits nuclear factor-kappa B activation The prodomain of caspase-1 enhances Fas-mediated apoptosis through facilitation of caspase-8 activation A diverse family of proteins containing tumor necrosis factor receptor-associated factor domains VIAF, a conserved inhibitor of apoptosis (IAP)-interacting factor that modulates caspase activation TRAF-interacting protein (TRIP): a novel component of the tumor necrosis factor receptor (TNFR)- and CD30-TRAF signaling complexes that inhibits TRAF2-mediated NF-kappaB activation 4-1BB and Ox40 are members of a tumor necrosis factor (TNF)-nerve growth factor receptor subfamily that bind TNF receptor-associated factors and activate nuclear factor kappaB Lymphotoxin-beta receptor signaling complex: role of tumor necrosis factor receptor-associated factor 3 recruitment in cell death and activation of nuclear factor kappaB CD30-dependent degradation of TRAF2: implications for negative regulation of TRAF signaling and the control of cell survival Tumor necrosis factor (TNF)-mediated kinase cascades: bifurcation of nuclear factor-kappaB and c-jun N-terminal kinase (JNK/SAPK) pathways at TNF receptor-associated factor 2 CD28-independent, TRAF2-dependent costimulation of resting T cells by 4-1BB ligand Two differently regulated nuclear factor kappaB activation pathways triggered by the cytoplasmic tail of CD40 Tumor necrosis factor receptor-associated factor (TRAF)-1, TRAF-2, and TRAF-3 interact in vivo with the CD30 cytoplasmic domain; TRAF-2 mediates CD30-induced nuclear factor kappa B activation Receptor activator of NF-kappaB recruits multiple TRAF family adaptors and activates c-Jun N-terminal kinase TRAF1 is a substrate of caspases activated during tumor necrosis factor receptor-alpha-induced apoptosis Tumor necrosis factor receptor-associated factors (TRAFs)Pleiotropic signal transduction mediated by human CD30: a member of the tumor necrosis factor receptor (TNFR) family Dominant negative mutants of TRAF3 reveal an important role for the coiled coil domains in cell death signaling by the lymphotoxin-beta receptor Activation of OX40 signal transduction pathways leads to tumor necrosis factor receptor-associated factor (TRAF) 2- and TRAF5-mediated NF-kappaB activation Identification and functional characterization of DR6, a novel death domain-containing TNF receptor Tumor necrosis factor receptor-associated factor (TRAF) 5 and TRAF2 are involved in CD30-mediated NFkappaB activation The TNF receptor family member CD27 signals to Jun N-terminal kinase via Traf-2 Gene targeting in the analysis of mammalian apoptosis and TNF receptor superfamily signaling.CD30 ligand (CD30L)-expressing acute myeloid leukemias: a new model of paracrine interactions for the regulation of blast cells proliferation.Interaction of tumor necrosis factor receptor-associated factor signaling proteins with the latent membrane protein 1 PXQXT motif is essential for induction of epidermal growth factor receptor expression Distinct motifs in the intracellular domain of human CD30 differentially activate canonical and alternative transcription factor NF-κB signaling TRAF2 recruitment via T61 in CD30 drives NFκB activation and enhances hESC survival and proliferation.Thermodynamic characterization of the interaction between TRAF2 and tumor necrosis factor receptor peptides by isothermal titration calorimetry Frequent expression of the variant CD30 in human malignant myeloid and lymphoid neoplasms.The in vivo function of a noncanonical TRAF2-binding domain in the C-terminus of CD40 in driving B-cell growth and differentiation CD30 induction of human immunodeficiency virus gene transcription is mediated by TRAF2 The Epstein-Barr virus LMP1 amino acid sequence that engages tumor necrosis factor receptor associated factors is critical for primary B lymphocyte growth transformation.Differential regulation of IkappaB kinase alpha and beta by two upstream kinases, NF-kappaB-inducing kinase and mitogen-activated protein kinase/ERK kinase kinase-1 Tumor necrosis factor receptor-associated factor 6 (TRAF6) stimulates extracellular signal-regulated kinase (ERK) activity in CD40 signaling along a ras-independent pathway.Induction of nuclear factor kappaB by the CD30 receptor is mediated by TRAF1 and TRAF2.BK Virus Load Associated with Serum Levels of sCD30 in Renal Transplant Recipients TNF superfamily: costimulation and clinical applications Galectin-1-mediated cell death is increased by CD30-induced signaling in anaplastic large cell lymphoma cells but not in Hodgkin lymphoma cells.AP-1 mediated relief of repressive activity of the CD30 promoter microsatellite in Hodgkin and Reed-Sternberg cells.Role of cellular tumor necrosis factor receptor-associated factors in NF-kappaB activation and lymphocyte transformation by herpesvirus Saimiri STP.Characterization of LMP-1's association with TRAF1, TRAF2, and TRAF3.

P2860

Q22253885-EEF5F2DF-2036-4AA4-A11A-FE842EF1D9E2 Q22254032-537FADDC-D8AB-4F48-B03F-43C38B0BF0D2 Q24291050-D345DC4A-CC9E-4296-8C8B-385BADE66518 Q24304221-6FE6791D-296D-450D-8F80-76E637DF3BD1 Q24313308-4072FF75-2B24-4DDD-8B45-23A9ADA9B8FC Q24533857-38FDF4BF-92B2-499A-B21C-043BFC67006D Q24564927-95BCCF2A-77CF-4D70-8164-1B987A23B9F4 Q24605401-FD782A06-8D67-44F8-9D16-6D376FE7CF47 Q24642851-5CCF5A4E-9DF3-416E-AF1D-FDB88951EC57 Q24647213-85A7F1F2-EC2C-4B95-A379-3E0AA858AD40 Q24676338-4809EA7F-6CFF-4BF1-84EE-CE2D7BEAD323 Q24679579-3222D4DD-6F5E-49DC-91AD-BB35485298F3 Q28137640-FF44A6D3-2B04-4BCD-8A3A-C4BE7BD74660 Q28138885-7F2018AC-CEE9-431F-9220-B17E70785437 Q28199382-BF3A998F-1C51-4B97-AD29-3E4BB5D862B5 Q28208696-E9F41138-D099-4AB0-9E10-02A68E06FE5D Q28255713-C152FE26-7539-4B93-A110-A10C6A9E6AC6 Q28263653-B670E27F-88C2-4E07-9942-706815CC53C2 Q28280342-8622233C-A6D4-4D5B-B014-1696B7C05216 Q28301504-B8D3B5A5-B60C-4598-9E82-46D4E5B4478F Q28589608-5E2F0CDA-40DB-439F-9167-FAF56EB4FC5D Q33713375-C72456F9-4D77-4F8C-A8E5-22976BF9E880 Q33747241-B5385DF1-5E7E-432A-8DEF-E262F13FDF2D Q33786551-71F64995-F767-4574-9D3A-6EECA8772EBD Q34428468-C39B6262-F087-41E4-AC04-4277A558F49D Q35125212-A10909F6-0B9B-4888-B75E-83877DA8122D Q35192167-5B1E5271-23E6-4CB5-8B60-F5E5E3CEE972 Q35788035-6B4BD2A2-C5FA-4C4E-92D5-5B81EA40D660 Q35850668-C1A2F678-6589-4C88-966E-DC7F815D4EA9 Q35996947-310D56D2-74CD-4E5A-A060-945551D25D16 Q35997566-BC51306F-B059-4060-AA92-2F6EDE3C39DB Q36004058-8C538D60-2F0C-419C-9013-549E6432712A Q36400170-2C289165-6E02-4810-A32B-51B5FF5B162F Q36566021-A7787BD8-DBED-4E36-AB15-1EBCA80B93F8 Q36718807-4EBE3F7A-70AB-484A-8F4F-1B5A19FBDF81 Q37266849-AE0C3465-2E49-48AF-9A52-3DA08D8F0364 Q38331230-5388C747-D984-40E6-A038-B16C3B351C2B Q39392332-E35AF860-09C8-453A-BB0F-AE981DCFA102 Q39550436-BC0B9BCB-88FB-4386-A47E-63F3EFF18CF2 Q39879963-7277BA01-FFEF-4401-8661-0D55BF07EE88

P2860

CD30 contains two binding sites with different specificities for members of the tumor necrosis factor receptor-associated factor family of signal transducing proteins

http://www.wikidata.org/entity/Q28281794

description

1996 nî lūn-bûn

@nan

1996 թուականի Մայիսին հրատարակուած գիտական յօդուած

@hyw

1996 թվականի մայիսին հրատարակված գիտական հոդված

@hy

1996年の論文

@ja

1996年論文

@yue

1996年論文

@zh-hant

1996年論文

@zh-hk

1996年論文

@zh-mo

1996年論文

@zh-tw

1996年论文

@wuu

name

CD30 contains two binding site ...... of signal transducing proteins

@ast

CD30 contains two binding site ...... of signal transducing proteins

@en

CD30 contains two binding site ...... of signal transducing proteins

@nl

type

label

CD30 contains two binding site ...... of signal transducing proteins

@ast

CD30 contains two binding site ...... of signal transducing proteins

@en

CD30 contains two binding site ...... of signal transducing proteins

@nl

prefLabel

CD30 contains two binding site ...... of signal transducing proteins

@ast

CD30 contains two binding site ...... of signal transducing proteins

@en

CD30 contains two binding site ...... of signal transducing proteins

@nl

P1433

Q28281794-19577F0A-ACF0-42C0-86CA-EA43D240D940

P1476

Q28281794-AF7752AC-01A3-479E-94DF-DF5E8FBDD03F

P2093

Q28281794-07B39A07-B5DE-461D-BACC-9A691CB8903A

Q28281794-0B03D589-5FDB-4E0F-9DA2-F36D9692E56D

Q28281794-1BD5D731-2A60-4794-814E-817C18180D53

Q28281794-93AFDF87-316D-44D6-96C7-C0E1C75B0D0B

Q28281794-A819DDB6-6B60-4B1E-9F5B-B9139F22ED8C

P2860

Q28281794-22315038-F447-4799-AE2D-20700CA2F4DB

Q28281794-31796F92-8C1D-4C4B-8671-8011B4088C35

Q28281794-3A4A53A0-6DF2-4D43-96B7-830755F2D993

Q28281794-3E26E628-2CAC-41AA-B674-EFDEC9F1CADF

Q28281794-4A90131D-92C4-42E5-9FA3-E6A64A7DECCE

Q28281794-4C5F18A8-0234-461C-8FDD-FBF93A36C183

Q28281794-4FB1E01C-39E4-4D97-8B2B-356A87773A74

Q28281794-5A7660F4-9E36-4EDD-BBB3-84F78DCB6BA5

Q28281794-5EC1C709-C6A6-45FB-9573-22D879ECFBED

Q28281794-7B52F6EC-CBCA-42D3-A151-F4E969CAF10D

P304

Q28281794-7A381B9F-6AC9-40F6-BE68-3DB00423A0F6

P31

Q28281794-0848AF83-5694-4DC6-9819-F1FCA103BE1F

P356

Q28281794-AA7598E3-FAB8-4327-954F-FA08D35F3B59

P407

Q28281794-59BC0ED0-0CCA-4BB4-95AB-0E652CA4A2D6

P433

Q28281794-0D0C798A-75A0-4B93-9FD1-EE38A871434F

P478

Q28281794-BD86112C-76B7-4A72-8431-0AA8EF99B7B3

P577

Q28281794-DD506C70-B53C-46BC-915B-D49F21C71052

P5875

Q28281794-EABFD75D-2872-428A-A9D2-6F565A6370A7

P698

Q28281794-362FA59F-A34B-4F39-B6E3-D117494C0D7A

P356

JBC.271.22.12852

P1433

Journal of Biological Chemistry

P1476

CD30 contains two binding site ...... of signal transducing proteins

@en

P2093

C B Thompson

http://www.w3.org/2001/XMLSchema#string

C S Duckett

http://www.w3.org/2001/XMLSchema#string

J L Van Dongen

http://www.w3.org/2001/XMLSchema#string

M C Gilfillan

http://www.w3.org/2001/XMLSchema#string

R W Gedrich

http://www.w3.org/2001/XMLSchema#string

P2860

A novel member of the TRAF family of putative signal transducing proteins binds to the cytosolic domain of CD40

Involvement of CRAF1, a relative of TRAF, in CD40 signaling

FADD, a novel death domain-containing protein, interacts with the death domain of Fas and initiates apoptosis

RIP: a novel protein containing a death domain that interacts with Fas/APO-1 (CD95) in yeast and causes cell death

Presence of a new conserved domain in CART1, a novel member of the tumor necrosis factor receptor-associated protein family, which is expressed in breast carcinoma

Suppression of apoptosis in mammalian cells by NAIP and a related family of IAP genes

CD30 antigen, a marker for Hodgkin's lymphoma, is a receptor whose ligand defines an emerging family of cytokines with homology to TNF

A novel family of putative signal transducers associated with the cytoplasmic domain of the 75 kDa tumor necrosis factor receptor

The TNF receptor 1-associated protein TRADD signals cell death and NF-kappa B activation

Molecular cloning and expression of a new member of the nerve growth factor receptor family that is characteristic for Hodgkin's disease

P304

12852-8

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1074/JBC.271.22.12852

http://www.w3.org/2001/XMLSchema#string

P407

P433

22

http://www.w3.org/2001/XMLSchema#string

P478

271

http://www.w3.org/2001/XMLSchema#string

P577

1996-05-31T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

14537742

http://www.w3.org/2001/XMLSchema#string

P698

8662842

http://www.w3.org/2001/XMLSchema#string